Intravenous leiomyomatosis with intracardiac extension: a single-institution experience

Am J Obstet Gynecol. 2009 Dec;201(6):574.e1-5. doi: 10.1016/j.ajog.2009.06.037. Epub 2009 Sep 2.

Abstract

Objective: The aim of this study was to outline the surgical management and outcomes for patients diagnosed with intravenous leiomyomatosis with intracardiac extension at a single institution.

Study design: This was a retrospective review of patients diagnosed with intravenous leiomyomatosis with intracardiac extension between 2002-2008.

Results: Four patients were identified. The surgical approach in 3 (75%) patients was a single-stage operation. Four (100%) patients presented with cardiac symptoms: 3 (75%) with syncope and 1 (25%) with an abnormal electrocardiogram. Mean age at presentation was 48 years (range, 42-58 years). Complete resection of tumor was obtained in 1 (25%) patient and 3 (75%) patients experienced incomplete resection. Mean follow-up, including surveillance imaging, was 25.5 months (range, 8-57 months) and all 4 patients (100%) are currently free of recurrence.

Conclusion: Surgical excision remains an effective therapy for treating patients with benign metastasizing leiomyomatosis. Incomplete surgical resection may result in favorable response.

MeSH terms

  • Adult
  • Female
  • Heart Neoplasms / secondary
  • Heart Neoplasms / surgery*
  • Humans
  • Leiomyomatosis / pathology
  • Leiomyomatosis / surgery*
  • Middle Aged
  • Neoplasm Invasiveness
  • Retrospective Studies
  • Treatment Outcome
  • Vascular Neoplasms / pathology
  • Vascular Neoplasms / surgery*